Sandbox:Mydah: Difference between revisions

Jump to navigation Jump to search
 
(132 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__  
__NOTOC__  
{{AE}} {{MSJ}}
{{AE}} {{MSJ}}
==Hyperprolactinemia resident survival guide==
==Dysentery in adults resident survival guide==
===Overview===
===Overview===
[[Hyperprolactinemia]] is defined as high circulating levels of [[prolactin]] in the blood. The cut-off values of serum [[prolactin]] for hyperprolactinemia are greater than 20 ng/ml in men and postmenopausal women and greater than 30ng/ml in premenopausal women.<ref name="pmid21296991">{{cite journal| author=Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA | display-authors=etal| title=Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. | journal=J Clin Endocrinol Metab | year= 2011 | volume= 96 | issue= 2 | pages= 273-88 | pmid=21296991 | doi=10.1210/jc.2010-1692 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21296991  }} </ref> [[Prolactin]] [[hormone]] is produced by lactotroph cells located in the anterior lobe of the [[pituitary gland]]. It is responsible for [[lactation]] and the development of [[breasts]] in females during pregnancy. Elevated levels of [[prolactin]] cause [[galactorrhea]], menstrual irregularities, and failure to conceive in females and erectile dysfunction, [[hypogonadism]], and [[infertility]] in males. This section provides a short and straight to the point overview of the [[hyperprolactinemia]].
[[Dysentery]] is described as [[blood]] with [[Human feces|stools]]. It occurs due to inflammatory reaction causing damage to the [[Gastrointestinal tract|intestinal tract]]. The patient also has a [[fever]], abdominal cramping, discomfort, increased [[Intestine|bowel]] movements, fecal urgency, and [[tenesmus]]. The underlying cause is mostly an infection due to [[bacteria]]. The main aim of the [[physician]] is to assess the severity of gastrointestinal symptoms, [[dehydration]], and [[hypovolemia]]. In [[patient|patients]] with severe symptoms, prompt investigations, and treatment should be carried out to reduce morbidity. This section provides a short and straight to the point overview of the [[dysentery]] in adults.


===Causes===
===Causes===
====Life-threatening Causes====
====Life-threatening Causes====
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
* Severe [[Burn|burns]] on the chest can cause [[hyperprolactinemia]] due to neural stimulation similar to suckling<ref name="pmid562902">{{cite journal| author=Morley JE, Dawson M, Hodgkinson H, Kalk WJ| title=Galactorrhea and hyperprolactinemia associated with chest wall injury. | journal=J Clin Endocrinol Metab | year= 1977 | volume= 45 | issue= 5 | pages= 931-5 | pmid=562902 | doi=10.1210/jcem-45-5-931 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=562902  }} </ref>.
 
*Does not include any known cause


====Common Causes====
====Common Causes====
*[[Pregnancy]]<ref name="pmid5024994">{{cite journal| author=Tyson JE, Hwang P, Guyda H, Friesen HG| title=Studies of prolactin secretion in human pregnancy. | journal=Am J Obstet Gynecol | year= 1972 | volume= 113 | issue= 1 | pages= 14-20 | pmid=5024994 | doi=10.1016/0002-9378(72)90446-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5024994  }} </ref>
*[[Shigellosis]]<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718 }} </ref>
*[[Lactation]]<ref name="pmid5024994">{{cite journal| author=Tyson JE, Hwang P, Guyda H, Friesen HG| title=Studies of prolactin secretion in human pregnancy. | journal=Am J Obstet Gynecol | year= 1972 | volume= 113 | issue= 1 | pages= 14-20 | pmid=5024994 | doi=10.1016/0002-9378(72)90446-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=5024994 }} </ref>
*[[Escherichia coli enteritis|Shiga toxin-producing E. coli]] (STEC) (eg, E. coli O157:H7) infection
*[[Prolactinoma]]<ref name="pmid840242">{{cite journal| author=Kleinberg DL, Noel GL, Frantz AG| title=Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. | journal=N Engl J Med | year= 1977 | volume= 296 | issue= 11 | pages= 589-600 | pmid=840242 | doi=10.1056/NEJM197703172961103 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=840242  }} </ref>
*[[Amoebiasis|Amebic dysentery]] caused by [[Entamoeba histolytica]]<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718 }} </ref>
* Injury to dopaminergic neurons in the hypothalamus ([[sarcoidosis]], [[craniopharyngioma]], and metastatic brain carcinoma)<ref name="pmid840242">{{cite journal| author=Kleinberg DL, Noel GL, Frantz AG| title=Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. | journal=N Engl J Med | year= 1977 | volume= 296 | issue= 11 | pages= 589-600 | pmid=840242 | doi=10.1056/NEJM197703172961103 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=840242  }} </ref>
*[[Salmonella]] infection
* Section of the hypothalamic-pituitary stalk
*[[Campylobacter]] infection<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718 }} </ref>
* Antipsychotics ([[risperidone]], [[haloperidol]], and [[phenothiazine]])<ref name="pmid11048906">{{cite journal| author=David SR, Taylor CC, Kinon BJ, Breier A| title=The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. | journal=Clin Ther | year= 2000 | volume= 22 | issue= 9 | pages= 1085-96 | pmid=11048906 | doi=10.1016/S0149-2918(00)80086-7 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11048906 }} </ref>
*Enteric viruses (eg, [[cytomegalovirus]] [CMV] or [[adenovirus]])<ref name="pmid29053792">{{cite journal| author=Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K | display-authors=etal| title=2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. | journal=Clin Infect Dis | year= 2017 | volume= 65 | issue= 12 | pages= e45-e80 | pmid=29053792 | doi=10.1093/cid/cix669 | pmc=5850553 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29053792 }} </ref>
* Selective serotonin reuptake inhibitors
*[[Inflammatory bowel disease]]
*[[Metoclopramide]]<ref name="pmid777023">{{cite journal| author=McCallum RW, Sowers JR, Hershman JM, Sturdevant RA| title=Metoclopramide stimulates prolactin secretion in man. | journal=J Clin Endocrinol Metab | year= 1976 | volume= 42 | issue= 6 | pages= 1148-52 | pmid=777023 | doi=10.1210/jcem-42-6-1148 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=777023  }} </ref>
*[[Ischemic colitis]]
*[[Domperidone]]<ref name="pmid7037817">{{cite journal| author=Sowers JR, Sharp B, McCallum RW| title=Effect of domperidone, an extracerebral inhibitor of dopamine receptors, on thyrotropin, prolactin, renin, aldosterone, and 18-hydroxycorticosterone secretion in man. | journal=J Clin Endocrinol Metab | year= 1982 | volume= 54 | issue= 4 | pages= 869-71 | pmid=7037817 | doi=10.1210/jcem-54-4-869 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7037817 }} </ref>
*[[Methyldopa]]<ref name="pmid1268617">{{cite journal| author=Steiner J, Cassar J, Mashiter K, Dawes I, Fraser TR, Breckenridge A| title=Effects of methyldopa on prolactin and growth hormone. | journal=Br Med J | year= 1976 | volume= 1 | issue= 6019 | pages= 1186-8 | pmid=1268617 | doi=10.1136/bmj.1.6019.1186 | pmc=1639736 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1268617  }} </ref>
*[[Verapamil]]
* Familial [[hyperprolactinemia]]<ref name="pmid24195502">{{cite journal| author=Newey PJ, Gorvin CM, Cleland SJ, Willberg CB, Bridge M, Azharuddin M | display-authors=etal| title=Mutant prolactin receptor and familial hyperprolactinemia. | journal=N Engl J Med | year= 2013 | volume= 369 | issue= 21 | pages= 2012-2020 | pmid=24195502 | doi=10.1056/NEJMoa1307557 | pmc=4209110 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24195502  }} </ref>
*[[Hypothyroidism]]<ref name="pmid4199418">{{cite journal| author=Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH| title=Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. | journal=J Clin Invest | year= 1973 | volume= 52 | issue= 9 | pages= 2324-9 | pmid=4199418 | doi=10.1172/JCI107421 | pmc=333037 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4199418 }} </ref>
*[[Chronic renal failure]]
* macroprolactinomas
*[[Physical exercise|Exercise]]


===Evaluation===
===Evaluation===
Shown below is an algorithm summarizing the diagnosis of [[hyperprolactinemia]] according to an Endocrine Society Clinical Practice guidelines<ref name="pmid21296991">{{cite journal| author=Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA | display-authors=etal| title=Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. | journal=J Clin Endocrinol Metab | year= 2011 | volume= 96 | issue= 2 | pages= 273-88 | pmid=21296991 | doi=10.1210/jc.2010-1692 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21296991 }} </ref><ref name="pmid24347930">{{cite journal| author=Majumdar A, Mangal NS| title=Hyperprolactinemia. | journal=J Hum Reprod Sci | year= 2013 | volume= 6 | issue= 3 | pages= 168-75 | pmid=24347930 | doi=10.4103/0974-1208.121400 | pmc=3853872 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24347930 }} </ref>:
Shown below is an algorithm summarizing the diagnosis of [[dysentery]] according to the American College of Gastroenterology guidelines.<ref name="pmid29053792">{{cite journal| author=Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K | display-authors=etal| title=2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. | journal=Clin Infect Dis | year= 2017 | volume= 65 | issue= 12 | pages= e45-e80 | pmid=29053792 | doi=10.1093/cid/cix669 | pmc=5850553 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29053792  }} </ref><ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref><ref name="pmid14702426">{{cite journal| author=Thielman NM, Guerrant RL| title=Clinical practice. Acute infectious diarrhea. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 1 | pages= 38-47 | pmid=14702426 | doi=10.1056/NEJMcp031534 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14702426 }} </ref><ref name="pmid12818275">{{cite journal| author=Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D | display-authors=etal| title=Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. | journal=Am J Gastroenterol | year= 2003 | volume= 98 | issue= 6 | pages= 1309-14 | pmid=12818275 | doi=10.1111/j.1572-0241.2003.07458.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12818275 }} </ref>
{{Family tree/start}}
{{Family tree/start}}
{{Family tree | | | | A01 | | | |A01= Characterize the symptoms  
{{Family tree | | | | A01 | | | |A01= <div style="float: center; text-align: left;">Characterize the symptoms:
* headache
* Duration of [[diarrhea]]
* oligomenorrhea
* Frequency and consistency of [[Human feces|stools]]
* infertility
* Presence of [[mucus]] and [[blood]] in the [[Human feces|stools]] }}
* hypogonadism
* erectile dysfunction
* galactorrhea}}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | B01 | | | |B01= Inquire about any present illness like hypothyroidism, chronic renal failure, and the use of medications known to cause hyperprolactinemia.}}
{{Family tree | | | | B01 | | | |B01= <div style="float: center; text-align: left;">To evaluate cause ask the following questions:
* Food history
* Occupational exposure (e.g. daycare center, poultry farm)
* Exposure to animals (pets, poultry, zoo, turtles)
* Recent travel to endemic areas
* Medication history (use of [[proton pump inhibitor]] increase susceptibility to [[infection]] with [[Shigella]]) }}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | |!| | | | | }}
{{Family tree | | | | C01 | | | |C01= <div style="float: center; text-align: left;">Does the patient have any of the following clinical signs or history?
{{Family tree | | | | |!| | | | | }}
* Old age (more than 70 years)
{{Family tree | | | | C01 | | | |C01= Measure serum prolactin. Elevated serum prolactin }}
* Presence of co-morbidities (advance [[heart disease]], severe immunocompromised state)
{{Family tree | | | | |!| | | | | }}
* [[Fever]] (>101.3 degrees Fahrenheit)
{{Family tree | | | | |!| | | | | }}
* Presence of severe symptoms
{{Family tree | | | | |!| | | | | }}
* Need for hospitalization
{{Family tree | | | | D01 | | | |D01= Mesure serum TSH. TSH levels elevated?}}
* Signs of [[dehydration]] (dry mucous membranes, sunken [[Eye|eyes]], decreased [[skin]] turgor, [[orthostatic hypotension]], [[oliguria]], dark-colored [[urine]], and [[Somnolence|drowsiness]] )
{{familytree | | |,|-|^|-|.| }}
abdominal tenderness on [[palpation]], [[rebound tenderness]], [[abdominal distention]], and abdominal rigidity. }}
{{familytree | | E01 | | |E02|E01= Yes | E02= No}}
{{Family tree | |,|-|-|^|-|-|-|-|.| | }}
{{familytree | | |!| | | |!| }}
{{Family tree | D01 | | | | | | D02 |D01= Yes |D02= No}}
{{familytree | | F01 | | |F02|F01= Treat hypothyroidism | F02= Perform the MRI with the contrast of the brain. Does it show any mass in the hypothalamic-pituitary region? }}
{{Family tree | |!| | | | | | | |!| | }}
{{familytree | | |!| | |,|-|^|-|.| }}
{{Family tree | E01 | | | | | | E02 |E01= <div style="float: center; text-align: left;">Perform the following [[Human feces|stool]] tests:
{{familytree | | G01 | |G02 | | G03 |G01= Levels of TSH and prolactin should be reassessed after 6-12 weeks. | G02=Yes. The levels of other pituitary hormones should be evaluated: Plasma corticotropins (ACTH), Serum TSH, Insulin-like growth factors, Follicle-stimulating hormone, Luteinizing hormone, Estradiol/ Testosterone | G03= No}}
* Bacterial culture for [[Salmonella]], [[Shigella]], and [[Campylobacter]].
{{Family tree/end}}
* Test for [[Shigella]] toxin and [[Escherichia coli|E. coli]] O157: H7
* Test for fecal [[leukocytes]] and [[lactoferrin]]. |E02= <div style="float: center; text-align: left;">Does the patient have any of the following:
* Clinical signs suggestive of [[inflammatory bowel disease]]
* Symptoms present for more than a week despite conservative management
* The patient is a health care worker or food handler (which can be a potential health hazard) }}
{{Family tree | |!| | | | | |,|-|^|-|.| }}
{{Family tree | F01 | | | | |F02| |F03| |F01= Is the fecal [[leukocytes]] or [[lactoferrin]] test positive? |F02= Yes |F03= No }}
{{Family tree |,|-|^|-|.| | | |!| | | |!| }}
{{Family tree |G01| |G02| |G03| |G04| G01=Yes |G02= No |G03=
* Perform routine [[Human feces|stool]] culture.
* Specific tests should be performed depending upon the patient’s history. |G04= No need to perform [[Human feces|Stool]] culture and additional tests. }}
{{Family tree |!| | | |!| | | }}
{{Family tree |F01| |F02| |F01= Test for [[Entamoeba histolytica]] |F02= [[Amoebiasis|Amebic dysentery]] highly unlikely. Look for other causative agents. }}


===Management===
===Treatment===
Shown below is an algorithm summarizing the treatment of [[hyperprolactinemia]]:   
Shown below is an algorithm summarizing the treatment of [[dysentery]] according to the Infectious Diseases Society of America clinical practice guidelines.<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref><ref name="pmid11100619">{{cite journal| author=Victora CG, Bryce J, Fontaine O, Monasch R| title=Reducing deaths from diarrhoea through oral rehydration therapy. | journal=Bull World Health Organ | year= 2000 | volume= 78 | issue= 10 | pages= 1246-55 | pmid=11100619 | doi= | pmc=2560623 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11100619  }} </ref><ref name="pmid20687081">{{cite journal| author=Christopher PR, David KV, John SM, Sankarapandian V| title=Antibiotic therapy for Shigella dysentery. | journal=Cochrane Database Syst Rev | year= 2010 | volume=  | issue= 8 | pages= CD006784 | pmid=20687081 | doi=10.1002/14651858.CD006784.pub4 | pmc=6532574 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20687081 }} </ref>
{{Family tree/start}}
{{familytree/start }}
{{Family tree | | | | A01 | | | |A01= The prolactinoma are treated in the following patients:
{{familytree | | | | | | | | A01 |A01= <div style="float: center; text-align: left;">Characterize the symptoms of the [[patient]]:
* A macroadenoma causing neurological symptoms such as headache and visual impairment due to compression of the optic chiasm.
* Presence of severe [[diarrhea]] along with systemic symptoms.
* Hypogonadism and galactorrhea due to increased prolactin secretion.
* Two or more clinical signs for [[dehydration]] (i.e. Sunken [[Eye|eyes]], dry [[mucous membrane]], reduced [[skin]] turgor, increased [[thirst]] ). }}  
* Infertility in women with disrupted luteal phase.
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }}
}}
{{familytree | | | B01 | | | | | | | | B02 | | |B01= Yes |B02= No }}
{{Family tree | |,|-|-|^|-|-|.| | }}
{{familytree | | | |!| | | | | | | | | |!| | | }}
{{Family tree | B01 | | | | B02 |B01= The drug of choice for prolactinoma are dopamine agonists as they decrease prolactin secretion and reduce the size of the prolactinoma. Cabergoline is the preferred drug because of its efficacy and lower incidence of nausea and side effects compared to bromocriptine. | B02= Transsphenoidal surgery is done in:
{{familytree | | | C01 | | | | | | | | C02 | | |C01= <div style="float: left; text-align: left;">
* Patients with unsuccessful treatment with dopamine agonists.  
* [[Fluid replacement]] therapy.
* A female patient with a known history of lactotroph macroadenoma who wishes to conceive. }}
* Empirical [[Antibiotic|antibiotics]] therapy.
{{familytree | |!| | | | | |!| | | }}
* The drug of choice is [[Quinolone|fluoroquinolones]] (500mg [[Levofloxacin (oral)]] once daily for 3 days).  If the symptoms do not improve in a few days, the patient should be switched to either [[azithromycin (oral)]] or [[cephalosporin]].  
{{Family tree | C01 | | | |C02| C01= The preferred initial dose of cabergoline for microadenoma is 0.25mg twice a week or 0.5mg once a week. The medicine should be given at dinner or bedtime to reduce the incidence of nausea and drowsiness. | C02= Transsphenoidal surgery has a high success rate in reducing serum prolactin to a normal level. }}
* Bismuth sulphate and [[loperamide]] to relieve abdominal cramps and discomfort. |C02= <div style="float: left; text-align: left;">
{{Family tree/end}}
* Oral [[fluid replacement]] therapy. Give [[Oral rehydration therapy|ORS]] solution for every [[Intestine|bowel]] movement. Approximately 2 liters of [[Oral rehydration therapy|ORS]] solution is given to the [[patient]].
* Antimicrobial therapy should be initiated on the basis of [[Human feces|stool]] culture results.
* Bismuth sulphate and [[loperamide]] can be given to relieve abdominal symptoms.
* Reassess hydration status after every 6 hours. }}
{{familytree | | | |!| | | | | | | | }}
{{familytree | | | D01 | | | | | | |D01= Assess [[patient]] for symptoms of [[hypovolemia]] (i.e. [[altered mental status]] with [[lethargy]] and [[unconsciousness]], weak [[Pulse|pulses]] , and inability to drink) }}
{{familytree | |,|-|^|.| | | | }}
{{familytree | D01 | | D02 | |D01= Yes |D02= No }}
{{familytree | |!| | | |!| | | }}
{{familytree | E01 | | E02 | |E01= <div style="float: left; text-align: left;">Patient has severe [[hypovolemia]].
* Give [[Intravenous therapy|parenteral]] [[fluid replacement]] with 5 % dextrose or [[Saline (medicine)|normal saline]] solution.
* Give rapid infusion initially and then slow infusion.
* The aim is to give 200 ml/kg in 24 hours with 100ml/kg in the first 4 hours of infusion.
* Reassess [[Hemodynamics|hemodynamic]] and hydration status of the [[patient]] after 6 hours. |E02= <div style="float: left; text-align: left;"> [[Patient]] has mild [[hypovolemia]].
* Give oral [[fluid replacement]] therapy.
* 2.2 to 4 liters of [[Oral rehydration therapy|ORS]] is given in the first 4 hours.
* Reassess [[Hemodynamics|hemodynamic]] and hydration status of the [[patient]] after 6 hours. }}
{{familytree/end}}


===Do's===
===Do's===
* “Hook effect” should be kept in consideration while assessing serum [[prolactin]] levels. Patients with macroadenoma can have artifactually low values of serum [[prolactin]] between 20 to 200 mcg/L in patients with high levels of serum [[prolactin]] i.e. 5000 mcg/L.<ref name="pmid9591215">{{cite journal| author=Petakov MS, Damjanović SS, Nikolić-Durović MM, Dragojlović ZL, Obradović S, Gligorović MS | display-authors=etal| title=Pituitary adenomas secreting large amounts of prolactin may give false low values in immunoradiometric assays. The hook effect. | journal=J Endocrinol Invest | year= 1998 | volume= 21 | issue= 3 | pages= 184-8 | pmid=9591215 | doi=10.1007/BF03347299 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9591215 }} </ref> This artifact is avoided by repeating the assay by dilution of serum.  
* Important clues regarding the etiology of dysentery can be narrowed down while taking history. If the patient has dysentery more than 16 hours after having an outdoor food consider [[Enterotoxigenic Escherichia coli|Enterotoxigenic ''E.coli'']]. There is an increased risk of acquiring the [[''Salmonella'']] infection in individuals exposed to turtles and poultry. People working in daycare have an increased risk of infection with enteric [[Virus|viruses]] and [[''Shigella'']].<ref name="pmid27068718">{{cite journal| author=Riddle MS, DuPont HL, Connor BA| title=ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. | journal=Am J Gastroenterol | year= 2016 | volume= 111 | issue= 5 | pages= 602-22 | pmid=27068718 | doi=10.1038/ajg.2016.126 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27068718  }} </ref>
* Cabergoline is preferred by women who wish to conceive as it is safe in early pregnancy. Though bromocriptine is also a safe choice with more evidence of reduced events of congenital defects.<ref name="pmid7062462">{{cite journal| author=Turkalj I, Braun P, Krupp P| title=Surveillance of bromocriptine in pregnancy. | journal=JAMA | year= 1982 | volume= 247 | issue= 11 | pages= 1589-91 | pmid=7062462 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7062462 }} </ref>
* Physicians can take a rectal swab in patients in whom stool samples cannot be obtained and immediate diagnosis is required.<ref name="pmid30944186">{{cite journal| author=Jean S, Yarbrough ML, Anderson NW, Burnham CA| title=Culture of Rectal Swab Specimens for Enteric Bacterial Pathogens Decreases Time to Test Result While Preserving Assay Sensitivity Compared to Bulk Fecal Specimens. | journal=J Clin Microbiol | year= 2019 | volume= 57 | issue= 6 | pages=  | pmid=30944186 | doi=10.1128/JCM.02077-18 | pmc=6535583 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30944186  }} </ref> Though the rectal swab has less sensitivity than [[Human feces|stool]] culture in identifying the causative agent.<ref name="pmid30315956">{{cite journal| author=Kotar T, Pirš M, Steyer A, Cerar T, Šoba B, Skvarc M | display-authors=etal| title=Evaluation of rectal swab use for the determination of enteric pathogens: a prospective study of diarrhoea in adults. | journal=Clin Microbiol Infect | year= 2019 | volume= 25 | issue= 6 | pages= 733-738 | pmid=30315956 | doi=10.1016/j.cmi.2018.09.026 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30315956 }} </ref>
* Patients with [[hyperprolactinemia]] with normal serum [[prolactin]] levels should be monitored for regular intervals after discontinuing [[cabergoline]]. There is a recurrence of [[hyperprolactinemia]] in these patients.
* If the clinician is suspecting a particular [[bacteria]], it should be mentioned while ordering the test. Certain [[bacteria]] require special culture media to grow and methods to be visualized. [[''Campylobacter jejuni'']] grows on the specific ‘CAMP’ agar plates at a particular temperature and environmental conditions. If infection with [[''Yersinia'']] is suspected, it should be specified as it is commonly overlooked.<ref name="pmid4014291">{{cite journal| author=Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH| title=Evaluation and diagnosis of acute infectious diarrhea. | journal=Am J Med | year= 1985 | volume= 78 | issue= 6B | pages= 91-8 | pmid=4014291 | doi=10.1016/0002-9343(85)90370-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4014291 }} </ref>  
 
* Physicians need to monitor the patients for the complications of the infection with certain [[bacteria]].  [[Bacteremia]] and [[reactive arthritis]] can occur with infection with non- typhoidal [[''Salmonella'']] and [[''Shigella'']].<ref name="pmid16621698">{{cite journal| author=Rodríguez M, de Diego I, Martínez N, Rosario Rodicio M, Carmen Mendoza M| title=Nontyphoidal Salmonella causing focal infections in patients admitted at a Spanish general hospital during an 11-year period (1991-2001). | journal=Int J Med Microbiol | year= 2006 | volume= 296 | issue= 4-5 | pages= 211-22 | pmid=16621698 | doi=10.1016/j.ijmm.2006.01.068 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16621698  }} </ref> The [[hemolytic-uremic syndrome]] can occur due to E 0157:H7 or [[''Shigella'']]. A neurological complication [[Guillain-Barré syndrome]] can occur with [[''Campylobacter'']] infection.
===Don'ts===
===Don'ts===
* Certain medications like [[risperidone]], [[domperidone]], [[methyldopa]], [[metoclopramide]], [[verapamil]], and [[cimetidine]] raise serum [[prolactin]] levels. These medications can blunt the effects of dopamine agonists.
* The empirical antimicrobial [[treatment]] for [[dysentery]] does not include [[treatment]] for [[Entamoeba histolytica|''E. histolytica'']][[Metronidazole]] (500mg thrice daily for 7 to days) should be administered to [[patient|patients]] only when trophozoites or cysts are visualized under a [[microscope]] in the [[Human feces|stool]] sample.<ref name="pmid590600">{{cite journal| author=Misra NP, Gupta RC| title=A comparison of a short course of single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis. | journal=J Int Med Res | year= 1977 | volume= 5 | issue= 6 | pages= 434-7 | pmid=590600 | doi=10.1177/030006057300100209 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=590600  }} </ref>
* The patients should be monitored for side effects. [[Cabergoline]] treatment in [[prolactinoma]] patients for more than three months can result in impulse control disorders. [[Hypersexuality]] is common in males and compulsive eating disorders in females.
* A complete metabolic profile is not routinely performed in [[patient|patients]] with [[dysentery]]. [[Serum]] electrolytes and [[glucose]] levels should only be measured in [[patient|patients]] who present with complications (i.e. [[altered mental status]], [[Seizure|seizures]], [[anuria]], [[oliguria]], and [[ileus]] ).


==References==
==References==
{{Reflist}}
{{Reflist}}
<references />

Latest revision as of 22:10, 26 August 2020


Associate Editor(s)-in-Chief: Mydah Sajid, MD[1]

Dysentery in adults resident survival guide

Overview

Dysentery is described as blood with stools. It occurs due to inflammatory reaction causing damage to the intestinal tract. The patient also has a fever, abdominal cramping, discomfort, increased bowel movements, fecal urgency, and tenesmus. The underlying cause is mostly an infection due to bacteria. The main aim of the physician is to assess the severity of gastrointestinal symptoms, dehydration, and hypovolemia. In patients with severe symptoms, prompt investigations, and treatment should be carried out to reduce morbidity. This section provides a short and straight to the point overview of the dysentery in adults.

Causes

Life-threatening Causes

Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.

  • Does not include any known cause

Common Causes

Evaluation

Shown below is an algorithm summarizing the diagnosis of dysentery according to the American College of Gastroenterology guidelines.[2][1][3][4]

Treatment

Shown below is an algorithm summarizing the treatment of dysentery according to the Infectious Diseases Society of America clinical practice guidelines.[1][5][6]

 
 
 
Characterize the symptoms:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To evaluate cause ask the following questions:
  • Food history
  • Occupational exposure (e.g. daycare center, poultry farm)
  • Exposure to animals (pets, poultry, zoo, turtles)
  • Recent travel to endemic areas
  • Medication history (use of proton pump inhibitor increase susceptibility to infection with Shigella)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any of the following clinical signs or history? abdominal tenderness on palpation, rebound tenderness, abdominal distention, and abdominal rigidity.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Perform the following stool tests:
 
 
 
 
 
Does the patient have any of the following:
  • Clinical signs suggestive of inflammatory bowel disease
  • Symptoms present for more than a week despite conservative management
  • The patient is a health care worker or food handler (which can be a potential health hazard)
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Is the fecal leukocytes or lactoferrin test positive?
     
     
     
     
    Yes
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    No
     
    * Perform routine stool culture.
    • Specific tests should be performed depending upon the patient’s history.
     
    No need to perform Stool culture and additional tests.
     
     
     
     
     
     
     
     
     
     
    Test for Entamoeba histolytica
     
    Amebic dysentery highly unlikely. Look for other causative agents.
     
     
     
     
     
     
     
     
    Characterize the symptoms of the patient:
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
     
     
     
     
     
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
  • Oral fluid replacement therapy. Give ORS solution for every bowel movement. Approximately 2 liters of ORS solution is given to the patient.
  • Antimicrobial therapy should be initiated on the basis of stool culture results.
  • Bismuth sulphate and loperamide can be given to relieve abdominal symptoms.
  • Reassess hydration status after every 6 hours.
  •  
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Assess patient for symptoms of hypovolemia (i.e. altered mental status with lethargy and unconsciousness, weak pulses , and inability to drink)
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Yes
     
    No
     
     
     
     
     
     
     
     
     
     
     
     
    Patient has severe hypovolemia.
    • Give parenteral fluid replacement with 5 % dextrose or normal saline solution.
    • Give rapid infusion initially and then slow infusion.
    • The aim is to give 200 ml/kg in 24 hours with 100ml/kg in the first 4 hours of infusion.
    • Reassess hemodynamic and hydration status of the patient after 6 hours.
     
    Patient has mild hypovolemia.
  • Give oral fluid replacement therapy.
  • 2.2 to 4 liters of ORS is given in the first 4 hours.
  • Reassess hemodynamic and hydration status of the patient after 6 hours.
  •  

    Do's

    • Important clues regarding the etiology of dysentery can be narrowed down while taking history. If the patient has dysentery more than 16 hours after having an outdoor food consider Enterotoxigenic E.coli. There is an increased risk of acquiring the ''Salmonella'' infection in individuals exposed to turtles and poultry. People working in daycare have an increased risk of infection with enteric viruses and ''Shigella''.[1]
    • Physicians can take a rectal swab in patients in whom stool samples cannot be obtained and immediate diagnosis is required.[7] Though the rectal swab has less sensitivity than stool culture in identifying the causative agent.[8]
    • If the clinician is suspecting a particular bacteria, it should be mentioned while ordering the test. Certain bacteria require special culture media to grow and methods to be visualized. ''Campylobacter jejuni'' grows on the specific ‘CAMP’ agar plates at a particular temperature and environmental conditions. If infection with ''Yersinia'' is suspected, it should be specified as it is commonly overlooked.[9]
    • Physicians need to monitor the patients for the complications of the infection with certain bacteria. Bacteremia and reactive arthritis can occur with infection with non- typhoidal ''Salmonella'' and ''Shigella''.[10] The hemolytic-uremic syndrome can occur due to E 0157:H7 or ''Shigella''. A neurological complication Guillain-Barré syndrome can occur with ''Campylobacter'' infection.

    Don'ts

    References

    1. 1.0 1.1 1.2 1.3 1.4 1.5 Riddle MS, DuPont HL, Connor BA (2016). "ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults". Am J Gastroenterol. 111 (5): 602–22. doi:10.1038/ajg.2016.126. PMID 27068718.
    2. 2.0 2.1 Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K; et al. (2017). "2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea". Clin Infect Dis. 65 (12): e45–e80. doi:10.1093/cid/cix669. PMC 5850553. PMID 29053792.
    3. Thielman NM, Guerrant RL (2004). "Clinical practice. Acute infectious diarrhea". N Engl J Med. 350 (1): 38–47. doi:10.1056/NEJMcp031534. PMID 14702426.
    4. Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D; et al. (2003). "Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation". Am J Gastroenterol. 98 (6): 1309–14. doi:10.1111/j.1572-0241.2003.07458.x. PMID 12818275.
    5. Victora CG, Bryce J, Fontaine O, Monasch R (2000). "Reducing deaths from diarrhoea through oral rehydration therapy". Bull World Health Organ. 78 (10): 1246–55. PMC 2560623. PMID 11100619.
    6. Christopher PR, David KV, John SM, Sankarapandian V (2010). "Antibiotic therapy for Shigella dysentery". Cochrane Database Syst Rev (8): CD006784. doi:10.1002/14651858.CD006784.pub4. PMC 6532574 Check |pmc= value (help). PMID 20687081.
    7. Jean S, Yarbrough ML, Anderson NW, Burnham CA (2019). "Culture of Rectal Swab Specimens for Enteric Bacterial Pathogens Decreases Time to Test Result While Preserving Assay Sensitivity Compared to Bulk Fecal Specimens". J Clin Microbiol. 57 (6). doi:10.1128/JCM.02077-18. PMC 6535583 Check |pmc= value (help). PMID 30944186.
    8. Kotar T, Pirš M, Steyer A, Cerar T, Šoba B, Skvarc M; et al. (2019). "Evaluation of rectal swab use for the determination of enteric pathogens: a prospective study of diarrhoea in adults". Clin Microbiol Infect. 25 (6): 733–738. doi:10.1016/j.cmi.2018.09.026. PMID 30315956.
    9. Guerrant RL, Shields DS, Thorson SM, Schorling JB, Gröschel DH (1985). "Evaluation and diagnosis of acute infectious diarrhea". Am J Med. 78 (6B): 91–8. doi:10.1016/0002-9343(85)90370-5. PMID 4014291.
    10. Rodríguez M, de Diego I, Martínez N, Rosario Rodicio M, Carmen Mendoza M (2006). "Nontyphoidal Salmonella causing focal infections in patients admitted at a Spanish general hospital during an 11-year period (1991-2001)". Int J Med Microbiol. 296 (4–5): 211–22. doi:10.1016/j.ijmm.2006.01.068. PMID 16621698.
    11. Misra NP, Gupta RC (1977). "A comparison of a short course of single daily dosage therapy of tinidazole with metronidazole in intestinal amoebiasis". J Int Med Res. 5 (6): 434–7. doi:10.1177/030006057300100209. PMID 590600.